Longitudinal Survey Analysis in Lymphoma Survivors (CLEAR Stress)
|ClinicalTrials.gov Identifier: NCT01469754|
Recruitment Status : Completed
First Posted : November 10, 2011
Last Update Posted : May 5, 2014
Posttraumatic Stress Disorder (PTSD) is a well-documented phenomenon that occurs in cancer survivors. PTSD is known to cause problems with anxiety, depression, and quality of life. Furthermore, there is little treatment available for cancer survivors who suffer from PTSD.
Posttraumatic Growth, however, is a lesser known phenomenon that also occurs in cancer survivors. It is a positive psychological phenomenon that occurs in some people who have suffered a traumatic event--the people who are able to note a "greater appreciation for life", a "stronger relationship with their family/friends," or a "new found level of spirituality" are examples of instances of posttraumatic growth.
Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress) is a study designed to compare the development of PTSD versus the development of Posttraumatic Growth in lymphoma patients at any stage of the cancer experience, regardless of treatment. The hypothesis is that posttraumatic growth, if it is significant, can reduce the impact of PTSD symptoms in the survivor.
|Condition or disease|
|Lymphoma Posttraumatic Stress Disorder Posttraumatic Growth Coping Resilience|
|Study Type :||Observational|
|Actual Enrollment :||97 participants|
|Official Title:||Coping With Lymphoma to Enhance Adjustment and Reduce Stress in Lymphoma Survivors|
|Study Start Date :||September 2011|
|Actual Primary Completion Date :||July 2013|
|Actual Study Completion Date :||September 2013|
- Posttraumatic Growth [ Time Frame: Measured at enrollment ]
- Posttraumatic Stress Disorder (PTSD) [ Time Frame: Measured at Enrollment ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01469754
|United States, New York|
|New York Presbyterian/Weill Cornell Center for Lymphoma and Myeloma|
|New York, New York, United States, 10065|
|Principal Investigator:||Regina A Jacob, MD||WCMC Research Fellow|